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Detecting the Effects of Toxic Agents on
Spermatogenesis Using DNA Probes
by Norman B. Hecht*
Advances in the molecular biology ofspermatogenesis suggest that DNA probes can be used to monitor
the effects of toxic agents in male germ cells of mammals. Molecular hybridization analyses with DNA
probes can provide a reproducible methodology capable ofdetecting changes ranging from massive dele-
tionstosinglebasepairsubstitutions inthegenomeofexposed individuals. Aconstantlyincreasingnumber
ofDNAprobes that can be used todetect such alterations in human sperm DNAexistforbothubiquitously
expressed proteins and for genes solely expressed in the testis. In this chapter, the currently available
testicular stage-specific and/or cell type-specific DNA probes and the techniques by which they can be
utilized in reproductive toxicology studies are discussed. The advantages, limitations, and future tech,
nological advances of this novel biological marker system for the human male reproductive system are
also considered.
Introduction
During the process ofspermatogenesis, diploid stem
cells differentiate first into functionally tetraploid cells
during meiosis and subsequently into haploid sperma-
tozoa. Following aseries ofstem cell divisions, primary
spermatocytes undergo meiosis, the interval in which
chromosomes synapse and genetic recombination oc-
curs. This phase of male germ cell development is fol-
lowed by two meiotic divisions that produce the haploid
round spermatid, a cell type that transforms into the
spermatozoon duringspermiogenesis, the haploid phase
of the spermatogenic cycle. Our precise knowledge of
the morphological events ofspermatogenesis, combined
with established testicular cell separation techniques,
has made the testis a most amenable organ to explore
biochemically.
The application of molecular biology to the study of
mammalian testicular differentiation is providing in-
vestigators with insights into many of the molecular
mechanisms that regulate male germ cell formation.
Gene expression during spermatogenesis is temporally
and spatially regulated withprecision with alarge num-
ber ofmacromolecules and organellesbeingsynthesized
in specific cell types during the lengthy continuum of
testicular cell differentiation (1). Although variants of
ubiquitous enzymes and structural proteins are ex-
pressed in many organs, the testis appears to be an
especially rich source of isozymes (2). Presumably
because ofthe specialized requirements essentialto pro-
duce a spermatozoon, a number ofunique testicular iso-
zymes coding for proteins such as lactate dehydrogen-
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ase, phosphoglycerate kinase, and cytochrome c have
evolved (Fig. 1) (1,2). In addition to the testicular iso-
zymes, a large number ofmale-specific structural pro-
teins of the maturing spermatid and the spermatozoon
have been identified (Fig. 1) (1). Biochemical analyses
ofthe differentiating haploid germ cells that transforn
intothehighlypolarizedspermatozoonsuggestwehave
only begun to define the many possible sperm-specific
molecular markers. As a result ofsuch studies and the
well-characterized sequence ofeventsleadingtothefor-
mation ofspermatozoa, efforts to monitor the effects of
toxic agents on male germ cells can use the substantial
knowledge base and the numerous DNA probes that
are currently available for the mammalian testis.
In this chapter, I shall discuss how present day re-
combinant DNA techniques can be used tomeasure the
effect of toxic agents on testicular cells. I shall first
describe some of the growing number of DNA probes
for the mammalian genome that are available and then
discuss several general approaches through which the
DNA probes can be used to screen for changes in male
germ cell DNA following exposure to toxic substances.
I shall especially focus my discussion on DNA markers
specific to testicular cell types or stages of spermato-
genesis that willprovide ameans to dissect the site and
define the mechanisms of action of toxic agents in the
mammalian testis. In addition to providing a summary
of DNA probes that now exist, it is hoped that this
report will stimulate development of improved DNA
monitoring procedures for compounds producing dele-
terious effects on male germ cells and lead in the near
future to the use of DNA probes as biological markers
for toxic agents and for risk assessment.N. B. HECHT
MOUSE SPERMATOGENESIS
FIGURE 1. Gene expression during spermatogenesis. This chart represents a summary of the temporal expression of a few representative
mouse testicular proteins discussed in a recent review of gene expression during spermatogenesis (1). Abbreviations: PGK-2, phospho-
glycerate kinase 2; MP, mouse protamine; TP, testis-protein; LDH-X, lactate dehydrogenase C4. A solid line indicates the approximate
interval when a protein is synthesized. A dashed line represents the interval when mRNA for a protein has been detected but the protein
appears not to be yet synthesized; i.e., the interval when the mRNA is stored as a ribonucleoprotein. An open box indicates the interval
when mP2 is synthesized as a precursor and subsequently processed to the mature form of the P2 protamine. Question marks represent
the author's uncertainty as to the exact time when TP synthesis terminates and to the identity of the 1.5 kB actin mRNA.
Overview of General Use of DNA
Probes
Molecular hybridization analysis with DNA probes
offers a superior, highly reproducible means to identify
subtle alterations in DNA sequence. In practice, a frag-
ment of DNA or RNA of known sequence is compared
to an equivalent experimental DNA fragment by an-
nealing the two and monitoring for base-pair mis-
matches. Withappropriate controls, differencesin DNA
sequence rangingfromchromosome deletions andtrans-
locations to single base-pair substitutions between the
control probe and the experimental DNA can be de-
tected. Such DNA alterations would reflect changes in-
duced inthe genome by exposure to atoxicagent. These
hybridization procedures are predicated upon our abil-
ity to obtain defined wild-type genes or sequences by
standard cloning procedures. These DNA probes would
then serve as reference sequences. When specific de-
fined probes are used, it will be possible to correlate
DNA changes with knowledge ofthe gene structure of
known probes. Nonspecific probes to noncoding or un-
defined regions of the genome would assay for general
changes in the DNA. Such procedures would, however,
be confined to monitoring identical changes in the DNA
of a large number of the cells examined. Methods to
analyze the DNA from single cells are badly needed
since fluorescence-activated cell sorters canreadily pro-
vide single cell samples for analysis. Although major
chromosomal alterations such as deletions in single cells
canbe detectedbyinsituhybridization, todetectsubtle
changes, amplification methods that increase the num-
ber ofcopies of a DNA fragment up to 106-fold must be
employed. Unfortunately, the amplification procedures
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in current use introduce errors athighfrequencies. Am-
plification procedures which introduce low frequencies
of error remain to be developed.
To detect lesions in DNA in the male reproductive
tract, DNA can be prepared from ejaculated sperma-
tozoa (3). The sequence of a particular gene or group of
genes would be compared to the wild-type sequence of
a well-characterized DNA probe by one or more ofthe
hybridization procedures described laterinthechapter.
Such an approach would be capable of detecting DNA
changes that are neither corrected by the male germ
cell repair mechanisms nor are of a sufficiently disas-
trous nature that they prevent spermatogenesis from
proceeding to completion. For the latter case, cytolog-
ical examination of ejaculates (if any sperm are pro-
duced) and/or testicular biopsies would be required.
Any defined region of the genome for which a DNA
probe is available can be monitored. Since toxic agents
forthe most part are assumed to actrandomly on DNA,
to apply DNA probes to human studies, a large group
of DNA probes homologous to as much of the human
genome as possible should be used. The greater the
number of sequences monitored, the more likely one
will successfully detect an alteration. The present lim-
itation that only a small part of the total genome can
be monitored at any one time is a serious shortcoming
of such a screening procedure. Despite this constraint,
the application of hybridization techniques with a size-
able group ofDNA probes offers one promising way to
start using a molecular approach to detect DNA dam-
age. Considering the rapidly evolving advances in mo-
lecular biology, it is likely that the technical problem of
surveillance of large regions of the genome of single
human cells will not be insurmountable.
DNA probes that could be used to detect genomic
alterations in the DNA from human sperm fall into two
categories: probes for ubiquitously expressed proteins
such as the globins or dihydrofolate reductase, and
probes for genes solely expressed in the testis. The
former class ofDNA probe offers aneasily obtained and
constantly increasing source of biological marker that
can be used to monitor random damage to the human
genome. The latter class of stage- or cell-type-specific
testicular DNA probe could be used to screen random
alterations in a defined part of the human genome. It
would have the additional advantage that, whenapplied
to an animal model system, the effect ofthe toxic agent
could be related to specific time periods oftesticular cell
differentation, assumingtheproduction ofaspecific tes-
ticular gene product has been disrupted. Such comple-
mentaryhuman and animal studies wouldprovide a use-
ful response comparison between mammals and allow
the mechanism(s) ofaction ofthe compound in question
to be investigated. Moreover, the availability of DNA
probes for testicular genes allows investigation of pos-
sible genetic and/or cell type "hot spots" (regions ofthe
genome highly susceptible to damage) during germ cell
differentiation. For these reasons, the next section of
this chapter will describe many of the testis-specific
DNAprobes currently beingused by investigators (Ta-
ble 1).
Testicular-Stage-Specific and Cell-
Type-Specific DNA Probes
To date, most attempts ofDNA cloning during sper-
matogenesis have been directed toward two intervals
of spermatogenesis, meiosis and spermiogenesis (4-6).
This is because the meiotic pachytene spermatocytes
and the haploid round spermatids represent two critical
time periods for gene expression during male germ cell
development. Moreover, highly enriched populations of
pachytene spermatocytes and round spermatids can be
readily obtained by cell separation techniques such as
the Staput unit gravity procedure or Percoll density
gradient centrifugation because of their marked size
differences and abundance inthe sexually mature testis
(1,7,8). Much progress has also been made in obtaining
molecularmarkers forcells suchas Sertoli cells,because
when isolated fromprepuberal animals, thistypeoftes-
ticular somatic cell can be easily cultured (9). The testis
offers an excellent systemto studygeneregulation dur-
ing differentiation and improvements in the ability to
isolate highlyenriched populations ofnumericallyminor
testicular cell types such as the type A and B sper-
matogonia are expected. The growing awareness of
these opportunities by molecular biologists suggests
that unique DNA probes for many nonabundant testic-
ular cell types will soon become available.
To date, the vast majority ofDNA probes for testic-
ulargenes have beenisolated from animal systems such
as the mouse, rat, or bull. The origin of these probes
will not be a problem for application to human DNA.
Since DNAprobes forhomologous genesinhumans and
othervertebrates sharesubstantialsequencehomology,
the animal probes can be used to isolate equivalent hu-
man sequences from human cDNA or genomic DNA
libraries. Investigators with long-term, committed in-
Table 1. Testicular DNA probes.
Type of probe Probe for
Meiotic Lactate dehydrogenase C4 (14)
Phosphoglycerate kinase 2 (17)
Cytochrome c,
Histone variants (21)
Postmeiotic Protamine 1 and 2 (22,23)
Testis protein (TP) (29,32)
Actin variant (34)
Tubulin variants (36,54)
Leydig cell Pro-opiomelanocortin (40)
Renin (41)
Sertoli cell Follicle-stimulating hornone (42)
Androgen-binding protein (43)
Ceruloplasmin (42)
Transferrin (42)
Sulfated glycoproteins (42)
Inhibin (44)
Somatomedin
Mullerian-inhibiting substance (45)
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terests in human toxicology studies should seriously
consider the direct isolation and characterization ofhu-
man DNA probes, as human testicular eDNA libraries
and human genomic DNA libraries are available. For
cases where both rodent and human probes are avail-
able, theanimalstudies canbeusedtovalidatetheDNA
probe marker for human use, and more importantly,
the animal studies canbeused torevealthe basic mech-
anismofactionbywhich specific chemicals interactwith
the genome.
Meiotic DNA Probes
Lactate Dehydrogenase C4. Lactate dehydrogen-
aseC4(LDHX)isoneofthebest-characterizedproteins
in the testis (2). It appears to be testis-specific and is
sypthesized initially during meiosis and in decreasing
amounts during early spermiogenesis (10). Since LDH
C4 is arelatively abundant testicular enzyme, LDH C4
mRNA represents as much as 0.18% oftotal functional
mRNA in mouse pachytene spermatocytes (11). Be-
cause LDH C4 is also present on the surface ofmature
spermatozoa, it has been used extensively in immuno-
contraceptive efforts (12). Although the protein se-
quence of LDH C4 from rodents has been known for
some time (13), only recently has a cDNA probe for
human LDH C4 been isolated (14).
Phosphoglycerate Kinase 2. Two distinct forms of
phosphoglycerate kinase (PGK) have been character-
ized in mammals. PGK-1 is an X-linked gene that is
expressed in somatic cells, whereasthe autosomally de-
rived isozyme, PGK-2, is specific to the testis (15). Al-
though the PGK-2 protein is synthesized during sper-
miogenesis, the gene appears to be initially transcribed
during meiosis with increased synthesis of PGK-2
mRNA in spermatids (16). Recent elegant studies of
the human PGK multigene family have produced de-
tailed sequence knowledge and DNA probes for these
important enzymes (17).
Cytochrome ct. Cytochrome c, the electron trans-
port protein from the mitochondrial respiratory chain,
exists in two forms in the testis (18). One variant, cy-
tochrome c,, is restricted to the testis, while the other
somatic variant, cytochrome c8, is presumably found in
all tissues. Indirect immunofluorescence with monospe-
cific antibodies first detects cytochrome ct in the mito-
chondriaofpachytene spermatocytes andinlaterstages
ofspermatogenesis, whereas cytochrome c8 is found in
the mitochondria of interstitial cells, Leydig cells, and
spermatogonia. Sequence analysis ofthe two mouse cy-
tochrome c molecules has revealed that cytochrome ct
differs from the cytochrome c8in 13 amino acid residues
(19). Although at this writing DNA probes only exist
for the somatic variant ofcytochrome c, the known se-
quence for the testicular form of cytochrome c would
allow appropriate oligonucleotide DNA probes to be
prepared. Sucholigonucleotides would facilitate the iso-
lation of cDNA or genomic DNA probes for human cy-
tochrome ct.
Meiotic Histone Variants. During spermatogene-
sis, a dramatic reorganization ofthe germ cell nucleus
occurs. This transformation, ultimately producing a
sperm nucleus with highly compacted DNA, is accom-
panied by the replacement of histones with a group of
transiently associated nuclear proteins and finally with
protamine (20). In addition tothe standard complement
of histone molecules found in mammalian cells, the
meiotic pachytene spermatocyte contains several ad-
ditional histone variants believed to be unique to the
testis. DNA sequence analysis of one testis-specific hi-
stonevariant, Hlt, revealsittobeauniquegeneproduct
and not a posttranslational modification of an existing
histone (21). The availability of a specific DNA probe
for one of these rat meiotic histones provides a means
to obtain the equivalent probe for the human male
meiotic histone gene. Probes for other testis-specific
histones can also be isolated.
Although currently few in number, these DNA
probes coding for well-characterized and essential
meiotic proteins provide a start in building a battery of
DNA probes to monitor gene expression during this
critical interval of spermatogenesis.
Postmeiotic DNA Probes
Protamines. The predominant proteins in mam-
malianspermatozoaaretheprotamines, agroupofsmall
arginine-rich DNA-binding proteins that aid in nuclear
DNA compaction during spermiogenesis (20). With the
exception of the mouse and human, most mammalian
spermatozoa have been reported to contain one type of
protamine. In the mouse, two protamine variants, mPl
and mP2, have beenidentified by DNA sequence analy-
sis of isolated cDNA clones (22,23). Protein sequence
studies have identified similar P1 and P2 human pro-
tamine variants (24-26). Although the P1 and P2 pro-
tamines differ substantially in size and sequence, in the
mouse they are closely linked on chromosome 16 and
are temporally and translationally regulated during
spermiogenesis (27). Itis likelythat the humanprotam-
ine genes are also chromosomally linked. Recently the
P1 human protamine has been demonstrated to be lo-
cated on human chromosome 16 (Reeves and Hecht,
unpublished observation).
Northern blots of RNA isolated from prepuberal
testes and from isolated meiotic and postmeiotic testic-
ular cell types reveal that the protamines are solely
expressed during the haploid interval of spermatoge-
nesis (4,28,29). Moreover, changes in length ofprotam-
ine mRNAs during spermatogenesis allow the protam-
ine probes to be used as molecular markers to evaluate
the extent of spermiogenesis in wild-type, mutant, or
chemically induced sterile animals (28). For instance,
usingthemPl-cDNAprobe, nomPl-mRNAisdetected
in testicular extracts of prepuberal mice up to 20 days
of age (a time when spermatogenesis has advanced to
meiosis), whereas a 580 nucleotide form ofmP1-mRNA
is present in the testes of22-day-old mice (early sper-
matids are present by day22), and a heterogenous pop-
ulation of580 and 450 nucleotide longmPl-mRNAs are
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present in the testes of sexually mature animals (Fig.
2) (29). Cell separation studies confirm that no mPl-
mRNA is present in pachytene spermatocytes, a 580
nucleotide mPl-mRNA is found in round spermatids,
and elongating spermatids contain an additional 450 nu-
cleotide length mRNA (28). These mRNA length
changes are a result of a partial deadenylation of the
protamine mRNAs when they move from the ribonu-
cleoprotein particle fraction ofthe cytoplasm (in round
spermatids) onto polysomes (in elongating spermatids).
Similar size changes occur for the P2 mouse protamine
and for P1 and P2 rat and hamster protamine mRNAs
(30).
To test the predictive value ofthe protamine cDNAs
as markers fortesticular germ cell differentation, three
mouse mutants-quaking, blind sterile, and testicular
feminization-have been examined (31). Quaking (qk) is
an autosomal mutation causing reduced myelinization
ofthe central nervous system and virtual azoospermia
in the homozygous male. Cytological examination re-
veals that the sterility in the male is caused by defects
in spermatid differentiation affecting sperm head shap-
ingandtail assembly. Northern blots oftesticular RNA
from homozygous males demonstrate that both the
1 2 .3
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FIGURE 2. Size of protamine 1 mRNA in testicular extracts of pre-
puberal and sexually mature mice. Ten ,ug aliquots of purified
testicular RNA from CD-i mice were denatured with glyoxal,
electrophoresed mn a 2% agarose gel, transferred to nitrocellulose
filters and hybridized to 82P-labeled mPl-cDNA. Lane 1: RNA
from 16-dayold animals; lane 2: RNA from 24-day-old animals;
lane 3: RNA from sexually mature animals. The numbers to the
right are nucleotide size markers. From Hecht et al. (31).
450 and 580 nucleotide mPl-mRNAs are present in the
testis. This indicates that a substantial number ofsper-
matids have differentiated to at least step. 12 of sper-
miogenesis, a result in agreement with the morphol-
ogical analysis ofthe mutant testis.
Blind sterile (bs) is an autosomal mutation producing
cataracts in both sexes and sterility inthe male. Analy-
sis of testicular RNA from bslbs males reveals a large
decrease in amount ofboth size classes ofmPl-mRNA,
a result in agreement with the cytological report of
markedly reduced numbers ofhaploid cell types in the
mutant testis.
Testicular feminization (Tfm) is an X-linked mutation
where chromosomally male mice fail to respond to tes-
tosteroneandhaveonlyvestigialtestis. NomPl-mRNA
is detected in extracts oftestes of TfmIY mice, an ob-
servation supported by the lack of differentiation of
postmeiotic germ cells.
The protamine genes appear to be excellent candi-
dates to serve as probes to monitor genomic defects
inducedduringspermiogenesis. Theyrepresenttwosin-
gle copy genes that express abundant postmeiotic tes-
ticularmRNAs essential forsperm function. Moreover,
the cDNAprobes showmuchhomologytothe DNAand
RNA ofmanyothervertebrates includingman. Several
laboratories are presently seeking to isolate human
probes for these male-specific DNA-binding proteins.
Testis Protein (TP). In mammals, histones are not
directly replaced by protamines but by a presumably
heterogeneous group of basic proteins called testis-
specific proteins (TP) (20). TPs are associated with the
spermatid nucleus during its transition from its nucleo-
somelike structuretothe smooth, branchingfibrilofthe
spermatozoan nucleus. The TPs are subsequently re-
placed by protamine during spermiogenesis. Recently,
cDNA probes for the mouse and rat TPs have been
identified (29,32). Phylogeneticstudiesindicateastrong
sequence conservation ofTPs in rodents and man. The
identical pattern of expression of mouse TP and pro-
tamine suggests that these three genes are temporally
regulated in the postmeiotic testicular cells and could
be used together to monitor postmeiotic gene expres-
sion.
Postmeiotic Actin. In mammals, actin is encoded
byamultigenefamilythatexpresses atleastsixdistinct
but closely related forms of actin. In addition to the
general role actin plays in cell motility and division,
secretion, organelle movement, and maintenance ofcel-
lular cytoarchitecture, testicular actins are likely to be
involved in chromosome movement during meiosis, in
shaping specific nuclear structures during spermioge-
nesis, and in spermnatozoan function (33). Although the
mRNAs that code for the cytoplasmic 1- and y-actin
isotypes have been detected in all testicular cell types
throughout spermatogenesis, mRNA encoding an ad-
ditional actin variant is first detected during spermi-
ogenesis (34). It should be possible to obtain several
distinct DNA probes to isotypes of actin that are ex-
pressed constitutively during spermatogenesis and to
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other actin isotypes that are temporally expressed in
specific stages or cell types.
Tubulins. Microtubules consist of heterodimers of
a- and P-tubulin. The a- and 1-tubulin subunits rep-
resent distinct sequences, each encoded by multigene
families. In the testis, the tubulins are involved in mi-
totic and meiotic divisions, in changes in cell shape and
structure, in the species-specific shaping of the sperm
nucleus, and in the synthesis ofthe axoneme of sperm
tails. Proteingelelectrophoresis andDNAcloningstud-
ies suggest that during spermatogenesis multiple iso-
forms ofat- and P-tubulin are expressed (33). One form
ofa-tubulin encodingamRNAof2.1 kB isfirstdetected
in postmeiotic cell types (35). Sequence analysis of a
mouse testicular a-tubulin cDNA reveals that the poly-
peptide it codes for differs from a conserved somatic
tubulin sequence in 20% of its amino acids (36). The
availability ofcDNAs for a number ofmouse testicular
a-tubulins provides a set of useful probes to monitor
the differential expression of several different cyto-
plasmic structural genes duringtesticular germ cell de-
velopment. A detailed study ofthe expression ofthe ,B-
tubulinmultigene familyduringspermatogenesis is also
likely to yield a group of temporally expressed cDNA
probes.
Additional Candidates forPostmeioticProbes. In
vivo and in vitro postmeiotic protein synthesis studies
and the many morphological changes in cell shape and
structure that occur during spermiogenesis indicate
that many additional unique macromolecules are syn-
thesized during spermiogenesis. Ongoing studies in
many laboratories suggest proteins such as acrosin, hy-
aluronidase, a sperm-specific enolase, and sperm tail
proteins such as the dyneins and outer dense-fiber pro-
teins will provide additional sources of stage-specific
DNA probes for this critical interval of spermatoge-
nesis. DNA probes are also available for some protoon-
cogenes such as c-abl and c-myc that are differentially
expressed during spermatogenesis. Although c-abl
mRNA is present in premeiotic, meiotic, and post-
meiotic cell types, a novel c-abl mRNA of distinct size
is first detected in postmeiotic cells (37). Because ofits
unique size, aprobe specifictothisshortened c-abltran-
scriptcouldbeprepared. Incontrast, theprotooncogene
c-myc appears not to be expressed in testicular germ
cells (38).
Stem Cell DNA Probes
Since spermatogonia make up only a few percent of
the cellsfoundinthesexuallymaturemammaliantestis,
it has been difficult to work biochemically with this cell
type, andnoDNAprobesuniquetospermatogoniahave
yet been isolated for this critical stage of spermatoge-
nesis. BecausealterationsinstemcellDNAwillproduce
heritable defects, amajoreffortneeds tobe commenced
to obtain an armamentarium ofDNA probes specific to
animal and human testicular stem cells. Recent im-
provements in testicular cell separation methodologies
make this possible because highly enriched populations
ofseveral types ofspermatogonia can be obtained from
the prepuberal testis. With poly-(A)+ RNA isolated
from enriched populations of spermatogonial cells, ra-
diolabeled cDNAs can be prepared, and a differential
hybridization approach similar to that previously used
toobtainpostmeioticcDNAscanbeconductedtoisolate
stem cell specific cDNAs (4). In brief, a total testis
cDNA library or a cDNA library enriched with sper-
matogonial cDNAs would be differentially hybridized
with radiolabeled cDNAs prepared from spermatogon-
ial, meiotic, or postmeiotic cell types. The cDNAs that
appear to be preferentially expressed in spermatogonia
would be isolated and their temporal appearance con-
firmed by the early appearance ofRNA in the testes of
prepuberal staged mice (4). DNA sequence analysis
could be used to help identify the proteins coded for by
the stem cell cDNAs. One possible candidate DNA
probe for a protein expressed in spermatogonia would
be the DNA coding for the H2A histone stem-cell var-
iantfound inmouse embryonic spermatogenic cells (39).
Testicular Somatic Cell DNA Probes
In addition to germ cells, the mammalian testis con-
tains several types of specialized somatic cells such as
the Sertoli, Leydig, macrophage, and peritubular cells
that are needed for normal male germ-cell production.
Although analysis of testicular somatic cells would re-
quire the invasive procedure of testicular biopsy, spe-
cific situations may warrant such an approach.
Leydig CeU DNA Probes. The endocrinology of
Leydig cells has been extensively studied because of
their importance in hormone production in the testis.
Recently, efforts havebeenmadetoutilize DNAprobes
to monitor Leydig cell function. Using the technique of
in situ hybridization, pro-opiomelanocortin (POMC)
mRNAs have recently been shown to be primarily lo-
calized to Leydig cells (40). Interestingly, POMC
mRNAtranscripts inthetestis (presumablyinthe Ley-
dig cells) are approximately 600 to 800 nucleotides in
length, whereas pituitary POMC mRNAs have been
reported to be 1150 nucleotides. This may indicate
either that differential gene expression of multiple
POMC genes occursinthetestis orthatthereis specific
mRNAprocessingforthePOMC Leydigcelltranscript.
It is likely that the POMC gene(s) shows tissue-specific
regulation for endorphin in the Leydig cell. Renin
mRNA has also been detected by in situ hybridization
histochemistry and immunocytochemistry in Leydig
cells (41). Considering theintense biochemicalattention
the Leydigcellreceives, thenumberofcell-type-specific
DNA probes for Leydig cells is likely to grow rapidly.
Sertoli CeUDNA Probes. In addition to serving as
the testicular target cell for the action of testosterone
and FSH, Sertoli cellshave beendescribed asthe nurse
cells ofthe seminiferous tubule. The importance ofthe
Sertoli cell in germ cell maturation has led to many in
vivo and cell culture studies of this somatic testicular
cell. Because of its mandatory role in germ cell devel-
opment, a large number of macromolecules have been
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showneithertobe secreted byortoactuponthe Sertoli
cell. DNAprobesnowexistformanyofthesemolecules,
including follicle-stimulating hormone (FSH), andro-
gen-binding protein (ABP), ceruloplasmin, transferrin,
sulfated glycoproteins, inhibin, somatomedin, and the
Mullerian-inhibiting substance (42-45). It is likely that
this list ofDNA probes will expand considerably in the
coming years and provide a sizeable number of molec-
ular markers to monitor Sertoli cell function.
Techniques that Utilize DNA Probes
to Detect the Effect of Toxic Agents
Toxic agents produce many different changes in
DNA, ranging from massive deletions and transloca-
tionstopointmutations. Compounds thatproducelarge
DNA lesions often inactivate genes or groups ofgenes
essential for organ function or even the survival ofthe
organism. Othertoxic agents, however, introduce more
subtle alterations such as single base-pair changes, usu-
ally at random sites throughout the genome.
When testicular function is monitored following ex-
posure to a toxic substance, some DNA alterations are
likely to directly affect spermatogenesis and fewer will
lead to defects that can be localized to specific cell types
with the stage-specific DNA probes. Therefore, careful
study ofthese genes is likely to provide etiologic infor-
mation on the stage of spermatogenesis at which the
toxic effects are manifested. Alterations in the DNA of
testicular stem cells which affect genes expressed dur-
ing spermatogenesis are the most likely to be detected
by hybridization analysis, since proliferation of such
stem cells would produce a reasonable number ofsper-
matozoa carryingthis alteration. Some toxic agents can
create heritable changes in the DNA of the testicular
stem cells which will not produce any immediate phen-
otypic effect in the exposed individual but will be ex-
pressed in the F1 generation.
Accepting these constraints, the human male repro-
ductive system is an excellent system to use to monitor
the relative mutagenicity ofcompounds. On an individ-
ual by individual basis, however, these tests provide
information on changes for a selected number ofgenes.
DNA can be readily obtained from ejaculated sperma-
tozoa, the cells that carry the paternal genome in the
form that ultimately is involved in fertilization. Such
studies with sperm DNA are noninvasive, inexpensive,
and repeated analyses can be made from one ejaculate.
Routine monitoring ofindividuals before workplace ex-
posure would establish the control. Moreover, when
specific perturbations to spernatogenesis are detected,
repeated sampling from one individual can be accom-
plished over an extended period of time to establish
when during the spermatogenic cycle a toxic agent has
acted. For instance, the detection of an alteration in
sperm DNA a few days after exposure to a toxic agent
indicates that the damage occurred in the mature sper-
matozoa in the epididymis. The detection ofchanges in
sperm DNA2weeks afterexposure would indicate that
the insult occurred duringspermiogenesis. Longertime
intervals between exposure and detection would indi-
cate sensitivity at earlier stages of spermatogenesis.
Although testicular stem cells are often more resistant
tomutationthanmeiotic orpostmeioticmalegermcells,
changes in stem cell DNA would be of more concern
because stem cells are maintained throughout the life
of the animal. Once an effect has been defined, animal
studies can be conducted to help localize the temporal
and spatial sites ofaction oftoxic agents. Although of-
feringamostpromisingapproachinthefuture, itshould
be remembered that many of these assays are predi-
cateduponourabilitytomonitorDNAchangesin single
spermatozoa, a technical problem that remains to be
solved.
Despite the growing number of testicular DNA
probes, the total number of such probes will always
represent only a miniscule fraction of the mammalian
genome. This intrinsic shortcoming of a DNA hybridi-
zation approach willbe alleviated bythe proposed char-
acterization of the human genome by restriction map-
ping and possible sequencing of specific chromosomes
orthe entire humangenome. Such studieswill generate
a vast number of useful human DNA probes and tech-
nological advances to monitor DNA.
With these considerations, several general screening
techniques will be discussed. Each will use DNA iso-
lated from ejaculated spermatozoa and will monitor for
alterations in DNA by identifying differences in DNA
sequence between a wild-type control and the experi-
mentallytreated sampleofDNA. Atfirstconsideration,
this approach appears to be seriously compromised by
the presence of the many polymorphisms reported for
human genes. However, detailed analysis ofone ofthe
best-studied human genes, the ,B-globin gene, has de-
tected only a limited number (five) ofpolymorphisms at
this locus (46). Extensive pedigree analyses for other
human genes is needed to provide a better understand-
ing of the true extent of human polymorphisms and to
help establish background levels for wild-type human
DNA probes.
Restriction-Fragment-Length
Polymorphisms
One popular mapping procedure uses restriction en-
zymes to detect DNA fragment-length polymorphisms
(47). Purified genomic DNAis digested with restriction
enzymes and analyzed by the Southern blot hybridiza-
tion procedure with a defined cDNA or genomic probe.
This relatively rapid procedure depends upon the ap-
pearance of a new DNA band or disappearance of an
old DNA band to indicate an alteration in the gene se-
quence. It is limited by the choice of restriction en-
zymes, and the probe used and it is usually necessary
to use many different restriction enzymes before a
change is detected. If the base-pair substitution does
not alter the restriction site(s) under study, the change
in the sequence will not be detected.
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Hybridization with Oligonucleotides
A second DNA monitoring procedure hybridizes ra-
diolabeled synthetic oligonucleotides that are homolo-
gous to mutant or wild-type DNAs from genomic DNA
(48). Depending upon the hybridization temperature or
washing conditions of the DNA duplexes, differential
melting of the mismatched or perfectly paired regions
ofDNA can be ascertained. Since one must synthesize
anoligonucleotide probe foreachregionmonitored, this
procedure would be satisfactory to screen mutations
only at specific defined sites but not throughout the
genome. Both the restriction-fragment-length poly-
morphism and oligonucleotide procedures are clearly
restricted to monitoring a small number of base pairs
in the genome.
Denaturing-Gradient Gel ElectrQphoresis
The next two procedures using denaturing-gradient
gel electrophoresis or RNA-DNA heteroduplexes are
capable ofscreening much longer DNA fragments and,
since they offer superior detection possibilities, will be
described in more detail.
Denaturing gradient gel electrophoresis provides a
systemto separate DNAmolecules bysmalldifferences
in DNAsequence (49,50). Moreover, thisapproachdoes
not require a close correspondence between the site of
abase-pairchangeandasharplydefined shortsequence.
Thismethod canutilize one-dimensional polyacrylamide
gels containing a gradient of formamide and urea to
separate duplex DNA fragments that differ by one or
more base-pair mismatches.
Double-stranded DNA fragments migrate into a gel
untiltheyreachthepartofthegelwherethedenaturant
concentrationis sufficient tomeltthe DNA. Differences
in melting temperature between wild-type and duplex
DNA fragments with one base-pair difference can be
resolved on the gel. Although virtually all single base
substitutionscanbedetected inclonedDNAfragments,
fortechnicalreasons, onlyabout25to40%ofallpossible
substitutions can be detected directlyingenomic DNA.
Despite this limitation, this procedure clearly offers a
more promising means to screen larger sections ofthe
genome than the restriction-fragment-length poly-
morphism and oligonucleotide methods.
A modification ofthis electrophoresis procedure uses
two-dimensional denaturing gradient gel electrophore-
sis to separate DNA fragments on the basis of length
and also bythe criterion ofDNA sequence. Thus, DNA
heteroduplexes can be distinguished by the response of
their structures to gradual changes in denaturant con-
centration in the gel. In theory, one should be able to
analyze a complex mixture of isomelting regions from
one gel and obtain an analysis of each melting region
by a second electrophoretic step. With additional im-
provements, this approach should allow large portions
of a genome to be examined.
RNA/DNA Heteroduplex Mismatches
A fourth method to detect alterations in DNA se-
quence is based on the hybridization of a radiolabeled
RNAprobetocloned orgenomicDNA(51). Mismatches
are detected by the enzymatic cleavage of the single
base pair mismatch of the wild-type RNA probe and
the experimental DNA by RNAse A. This procedure
uses vector systems such as SP6 which provide aready
source ofradiolabeled RNA transcripts from the DNA
insert under investigation. A current limitation ofthis
technique is the inability ofRNAse A or other RNAses
to routinely detect and cut mismatches other than C:A
mismatches. This reduces the number of mismatches
between the heteroduplexes that can be detected to 1
out of 12 possibilities. Although this approach is now
rather limited, future modifications are likely to extend
its scope.
Pulsed Field Gel Electrophoresis
Denaturing gradient gel electrophoresis and ribonu-
clease cleavage of mismatches in RNA:DNA hetero-
duplexes both detect differences between control (wild-
type) and mutant (experimentally treated) DNA se-
quences. Both procedures are limited by the small frac-
tion of the genome that can be analyzed. A new tech-
nique, pulsed-field gel electrophoresis, developed to
allow separation offragments of DNA larger than can
be prepared by other procedures, may overcome this
problem(52,53). GenomicDNA, isolatedsothatrandom
breaks are avoided, is cut into specific size fragments
by addition of a rare-cutter restriction enzyme. The
resulting approximately 3000 fragments average about
2 x 106 nucleotides in length. Hybridization of DNA
probes to these fragments will allow much more ofthe
genome to be routinely examined.
Conclusions
The application ofDNA probes to monitorthe effects
oftoxicagents onhumanspermatogenesisoffersanovel
biologicalmarkersystemforthe male reproductive sys-
temprovidingspecificobstacles canbesurmounted. The
basic technique ofmolecular hybridization is highly re-
producible and canreadilydetectDNAchangesranging
in magnitude from base pair substitutions to chromo-
some deletions. Although hybridization techniques are
relativelytediousandcostly, thewidespreadapplication
of this technology to problems in health and medical
science suggests that vast improvements in the auto-
mation of these procedures will soon be forthcoming.
The primary limitations, to date, for the application of
DNA probe technology to evalute genomic DNA alter-
ations in germ cells are: DNA probes are available for
only a very minute part of the genome; current proce-
dures severely limit the number of probes that can be
assayed at any one time, thereby restricting the per-
centage of the genome examined in each analysis; the
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DNA from single cells, e.g., spermatozoa, cannot be
analyzed. It is hoped that in the not too distant future,
procedures will be developed to monitor large frag-
ments ofgenomic DNA with a battery of DNA probes
covering vast regions ofthe human genome. Advances
in fluorescence detection of DNA combined with com-
puter imaging of automated samples will aid in the
analysis of DNA from single cells.
This work was supported by a National Institutes ofHealth Grant
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